Encouraging News in Metastatic Breast Cancer Treatment 🎯
📅 Posted on September 30, 2024 💡 What's This About? A new study examined the combination of two drugs – Eribulin and Carboplatin – in patients with "triple negative" metastatic…
Encouraging News in Bladder Cancer Treatment 🎯
Posted on September 19, 2024 What's This About? 🔍 A promising new study examined the combination of two drugs, Rogaratinib Plus Atezolizumab, in patients with locally advanced or metastatic bladder cancer,…
A Story of Hope, Persistence, and an Moving Achievement for Daria, a 5-year-old Girl from Poland Facing a Brain Tumor
📅 On September 3, 2024, we received a touching request from a family in Poland, whose young daughter Daria, age 5, was diagnosed with a brain stem tumor after a…
🌟 New Discoveries in Colon Cancer Treatment with a New Immunotherapy Combination: What Does the New Study Say? 🌟
📢 Published on June 13, 2024 Researchers from Stanford University have published the results of a study in Nature Medicine that examined the effectiveness of the treatment combining Botensilimab and…
July 21, 2012. Toledo, Spain. An instructor and his passenger parachute. A hot summer day in central Spain.
⭐ Roni: “I feel like my life has been saved in the last hour we’ve been talking, unbelievable.” ⭐
👉Fate can change in an instant. For Roni, 54 years old, a father and husband, that moment came when he reached out to us. Roni was diagnosed with salivary gland…
3d rendering of a plastic jar with medical pills on a hand truck on blue background. Medicine and health. Bottles and containers. Healthcare industry.
🏥 When Professionalism and Humanity Meet: How We Helped Michal ❤️
We want to share with you the touching story of Michal (a pseudonym), a 32-year-old incredible woman battling metastatic breast cancer, who we have been supporting for some time. Our…
Young content brunette wearing bright sweater and hat showing two fingers at camera.
🌟 **Which is Better for Cancer Patients: Investigational Drugs or Standard Drugs?** 🌟
📢 ** Published on April 30, 2024** Researchers from McGill University in Montreal conducted a comprehensive study involving 128 clinical trials. In this study, there were two groups of patients:…
Colorectal Cancer - Krazati with or without Erbitux in Mutated KRAS G12C
Colorectal Cancer – Krazati with or without Erbitux in Mutated KRAS G12C
Background Adagrasib, also called “Krazati”, is a tablet taken by mouth which inhibits KRAS G12C mutation. It has shown clinical activity in pretreated patients with several tumor types, including colorectal…
Cannabidiol oil failed to overcome palliative care in advanced cancer
Cannabidiol oil failed to overcome palliative care in advanced cancer
Background The use of cannabis for therapeutic benefit has risen exponentially over the past few years with strong public belief in its benefit. This is despite very limited evidence of…